vs
New Fortress Energy Inc.（NFE）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
New Fortress Energy Inc.的季度营收约是Orthofix Medical Inc.的1.5倍（$326.2M vs $219.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -259.7%，领先258.6%），Orthofix Medical Inc.同比增速更快（2.0% vs -7.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-134.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -26.8%）
New Fortress Energy Inc.是一家全球能源基础设施企业，主要开发、持有并运营液化天然气进出口终端、天然气供应网络及低碳能源项目，服务美洲、加勒比地区客户，致力于提供低成本、低排放的能源解决方案。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
NFE vs OFIX — 直观对比
营收规模更大
NFE
是对方的1.5倍
$219.9M
营收增速更快
OFIX
高出8.9%
-7.0%
净利率更高
OFIX
高出258.6%
-259.7%
自由现金流更多
OFIX
多$151.6M
$-134.8M
两年增速更快
OFIX
近两年复合增速
-26.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $326.2M | $219.9M |
| 净利润 | $-847.1M | $-2.2M |
| 毛利率 | 35.5% | 71.1% |
| 营业利润率 | -193.0% | 0.2% |
| 净利率 | -259.7% | -1.0% |
| 营收同比 | -7.0% | 2.0% |
| 净利润同比 | -277.4% | 92.4% |
| 每股收益（稀释后） | $-3.03 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NFEOFIX
| Q4 25 | $326.2M | $219.9M | ||
| Q3 25 | $240.3M | $205.6M | ||
| Q2 25 | $228.1M | $203.1M | ||
| Q1 25 | $384.9M | $193.6M | ||
| Q4 24 | $350.7M | $215.7M | ||
| Q3 24 | $446.0M | $196.6M | ||
| Q2 24 | $291.2M | $198.6M | ||
| Q1 24 | $609.5M | $188.6M |
净利润NFEOFIX
| Q4 25 | $-847.1M | $-2.2M | ||
| Q3 25 | $-263.0M | $-22.8M | ||
| Q2 25 | $-546.5M | $-14.1M | ||
| Q1 25 | $-175.4M | $-53.1M | ||
| Q4 24 | $-224.4M | $-29.1M | ||
| Q3 24 | $9.3M | $-27.4M | ||
| Q2 24 | $-88.9M | $-33.4M | ||
| Q1 24 | $54.1M | $-36.0M |
毛利率NFEOFIX
| Q4 25 | 35.5% | 71.1% | ||
| Q3 25 | 18.1% | 72.2% | ||
| Q2 25 | 8.4% | 68.7% | ||
| Q1 25 | 21.4% | 62.8% | ||
| Q4 24 | 17.6% | 69.0% | ||
| Q3 24 | 27.1% | 68.7% | ||
| Q2 24 | 23.8% | 67.8% | ||
| Q1 24 | 62.4% | 67.5% |
营业利润率NFEOFIX
| Q4 25 | -193.0% | 0.2% | ||
| Q3 25 | -37.4% | -8.3% | ||
| Q2 25 | -170.3% | -7.9% | ||
| Q1 25 | -3.3% | -25.2% | ||
| Q4 24 | 65.0% | -5.3% | ||
| Q3 24 | 17.8% | -9.6% | ||
| Q2 24 | 12.3% | -12.5% | ||
| Q1 24 | 30.4% | -15.6% |
净利率NFEOFIX
| Q4 25 | -259.7% | -1.0% | ||
| Q3 25 | -109.4% | -11.1% | ||
| Q2 25 | -239.6% | -6.9% | ||
| Q1 25 | -45.6% | -27.4% | ||
| Q4 24 | -64.0% | -13.5% | ||
| Q3 24 | 2.1% | -13.9% | ||
| Q2 24 | -30.5% | -16.8% | ||
| Q1 24 | 8.9% | -19.1% |
每股收益（稀释后）NFEOFIX
| Q4 25 | $-3.03 | $-0.05 | ||
| Q3 25 | $-0.96 | $-0.57 | ||
| Q2 25 | $-1.99 | $-0.36 | ||
| Q1 25 | $-0.65 | $-1.35 | ||
| Q4 24 | $-1.10 | $-0.76 | ||
| Q3 24 | $0.03 | $-0.71 | ||
| Q2 24 | $-0.42 | $-0.88 | ||
| Q1 24 | $0.23 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $226.5M | $82.0M |
| 总债务越低越好 | $8.2B | — |
| 股东权益账面价值 | $182.6M | $450.0M |
| 总资产 | $10.6B | $850.6M |
| 负债/权益比越低杠杆越低 | 44.78× | — |
8季度趋势，按日历期对齐
现金及短期投资NFEOFIX
| Q4 25 | $226.5M | $82.0M | ||
| Q3 25 | $145.2M | $62.9M | ||
| Q2 25 | $551.1M | $65.6M | ||
| Q1 25 | $447.9M | $58.0M | ||
| Q4 24 | $492.9M | $83.2M | ||
| Q3 24 | $90.8M | $30.1M | ||
| Q2 24 | $133.0M | $26.4M | ||
| Q1 24 | $143.5M | $27.0M |
总债务NFEOFIX
| Q4 25 | $8.2B | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | $8.9B | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益NFEOFIX
| Q4 25 | $182.6M | $450.0M | ||
| Q3 25 | $1.1B | $442.5M | ||
| Q2 25 | $1.3B | $458.3M | ||
| Q1 25 | $1.8B | $458.3M | ||
| Q4 24 | $1.9B | $503.1M | ||
| Q3 24 | $1.6B | $525.9M | ||
| Q2 24 | $1.6B | $546.0M | ||
| Q1 24 | $1.7B | $570.3M |
总资产NFEOFIX
| Q4 25 | $10.6B | $850.6M | ||
| Q3 25 | $12.0B | $832.6M | ||
| Q2 25 | $12.0B | $837.2M | ||
| Q1 25 | $13.1B | $823.1M | ||
| Q4 24 | $12.9B | $893.3M | ||
| Q3 24 | $12.0B | $867.9M | ||
| Q2 24 | $11.4B | $882.0M | ||
| Q1 24 | $10.9B | $906.0M |
负债/权益比NFEOFIX
| Q4 25 | 44.78× | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | 4.74× | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-76.2M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-134.8M | $16.8M |
| 自由现金流率自由现金流/营收 | -41.3% | 7.6% |
| 资本支出强度资本支出/营收 | 18.0% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.4B | $-1.3M |
8季度趋势，按日历期对齐
经营现金流NFEOFIX
| Q4 25 | $-76.2M | $27.7M | ||
| Q3 25 | $-171.0M | $12.4M | ||
| Q2 25 | $-329.0M | $11.6M | ||
| Q1 25 | $-7.2M | $-18.4M | ||
| Q4 24 | $445.3M | $23.7M | ||
| Q3 24 | $-20.0M | $11.7M | ||
| Q2 24 | $113.9M | $9.0M | ||
| Q1 24 | $63.0M | $-18.6M |
自由现金流NFEOFIX
| Q4 25 | $-134.8M | $16.8M | ||
| Q3 25 | $-231.6M | $2.5M | ||
| Q2 25 | $-726.7M | $4.5M | ||
| Q1 25 | $-262.3M | $-25.1M | ||
| Q4 24 | $-210.3M | $15.2M | ||
| Q3 24 | $-367.0M | $6.3M | ||
| Q2 24 | $-493.2M | $-360.0K | ||
| Q1 24 | $-457.9M | $-29.1M |
自由现金流率NFEOFIX
| Q4 25 | -41.3% | 7.6% | ||
| Q3 25 | -96.4% | 1.2% | ||
| Q2 25 | -318.6% | 2.2% | ||
| Q1 25 | -68.2% | -13.0% | ||
| Q4 24 | -60.0% | 7.0% | ||
| Q3 24 | -82.3% | 3.2% | ||
| Q2 24 | -169.3% | -0.2% | ||
| Q1 24 | -75.1% | -15.4% |
资本支出强度NFEOFIX
| Q4 25 | 18.0% | 4.9% | ||
| Q3 25 | 25.2% | 4.8% | ||
| Q2 25 | 174.4% | 3.5% | ||
| Q1 25 | 66.3% | 3.5% | ||
| Q4 24 | 187.0% | 4.0% | ||
| Q3 24 | 77.8% | 2.7% | ||
| Q2 24 | 208.4% | 4.7% | ||
| Q1 24 | 85.5% | 5.6% |
现金转化率NFEOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -2.15× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.16× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NFE
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
